Q&A: George Church’s Genome Up for Auction

A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: © ISTOCK.COM,
NOBI_PRIZUE

In 2017, Harvard University genomics pioneer George Church teamed up with two young scientists to launch Nebula Genomics, a sequencing service with an emphasis on transparency with regard to how genomic data are used. Now, in an effort to bring more attention to issues surrounding data ownership, the company is putting Church’s genome up for auction as a nonfungible token (NFT), a form of cryptocurrency that provides proof of ownership of a digital or physical object and has shot to popularity in recent years with the rise of blockchain technology.

Church’s genome was the one of the first to be sequenced, and it was the first to be made publicly available, along with his medical records, multiomics data, and other information, as part of the Personal Genome Project (PGP) he launched in 2005. “The NFT was not my idea, but hopefully it is a good idea,” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
Image of people clinking glasses with various alcoholic beverages at a table.
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
An illustration of colorful shapes.

Real-Time Image-Enabled Cell Sorting 

BD
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
Wastewater surveillance conceptual visualization of a water droplet containing different microorganism

Elevating Wastewater Epidemiology with Microfluidics

Products

Takara Bio

Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions

Sapio Sciences

Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology

Biotium Logo

Biotium Unveils the Most Sensitive Stains for DNA or RNA with New EMBER™ Ultra Agarose Gel Kits

Cytosurge Logo

Cytosurge Announces Strategic Leadership Transition